Skip to main content

Day: April 17, 2023

Aurora Spine Announces Initial Surgeries Conducted Using its SiLO TFX™ MIS Sacroiliac Joint Fixation System

Carlsbad, Calif., April 17, 2023 (GLOBE NEWSWIRE) — Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) (OTCQB: ASAPF), a designer and manufacturer of innovative medical devices that improve spinal surgery outcomes, today announced that initial surgeries using its proprietary SiLO TFX™ MIS Sacroiliac Joint Fixation Device have been performed in recent weeks. Over a dozen patients were implanted with the newly FDA-approved device and all procedures using the device were successful. The patented, minimally invasive SiLO TFX MIS Sacroiliac Joint Fixation System is intended for sacroiliac joint fusion for conditions including sacroiliac joint disruptions and degenerative sacroiliitis. The SiLO TFX MIS Sacroiliac Joint Fixation System includes a Transfixing-Cone, an ilium screw, a sacrum screw and associated...

Continue reading

With 17.4% CAGR, Femtech Market Size to Hit USD 20.59 Billion by 2030

As per the report by Fortune Business Insights, the global femtech market size is projected to reach USD 20.59 Billion in 2030. The market size was valued USD 6.69 Billion in 2023, at a CAGR of 17.4% during the forecast period, 2023-2030 Pune, India, April 17, 2023 (GLOBE NEWSWIRE) — The global femtech market size was valued at USD 5.79 billion in 2022. The market is projected to grow from USD 6.69 billion in 2023 to USD 20.59 billion by 2030, exhibiting a CAGR of 17.4% during the forecast period. Femtech refers to technology products related to females. It includes technology products, software, and services. The primary focus is to develop tech-enabled solutions to cater to the unmet rising need for women’s health disorders. Rising funding and investments coupled with an increasing number of startups with novel femtech solutions...

Continue reading

With 9.7% CAGR, Sepsis Diagnostics Market Size to Reach USD 1,603.3 Million by 2030

According to Fortune Business Insights, Sepsis Diagnostics Market size is anticipated to reach USD 1,603.3 Million by 2030, the market size was USD 770.4 Million in 2022 and is anticipated to rise at a CAGR of 9.7%. Pune, India, April 17, 2023 (GLOBE NEWSWIRE) — The global sepsis diagnostics market size was valued at USD 770.4 million in 2022. The market is projected to grow from USD 840.5 million in 2023 to USD 1,603.3 million by 2030, exhibiting a CAGR of 9.7% during the forecast period. When the body reacts to an infection by damaging its own tissues, it is said to be experiencing sepsis. Infections caused by bacteria is one of the most frequent causes. This condition can also be brought on by other infections, including viral and fungal infections. Sepsis, severe sepsis, and septic shock are the three stages of the illness....

Continue reading

Helius Medical Technologies to Spotlight Expanded Authorizations for its PoNS Device at 2023 American Academy of Neurology Annual Meeting, Booth 1685

MS, Stroke and mmTBI Cover Broader Set of Indications Across North American Markets NEWTOWN, Pa., April 17, 2023 (GLOBE NEWSWIRE) — Helius Medical Technologies (NASDAQ: HSDT) today announced it will exhibit at the American Academy of Neurology (AAN) Annual Meeting for the first time since its Portable Neuromodulation Stimulator (PoNS) device became commercially available in both the United States and Canada. Helius’s presence at the conference comes at a time when PoNS is seeking additional indications for neurological conditions that lead to gait and/or balance impairment. The U.S. Food and Drug Administration authorized PoNS to be used for therapeutic management of gait deficit due to multiple sclerosis (MS), as well as a Breakthrough Devices Designation in stroke. Health Canada authorized PoNS for short-term treatment of balance...

Continue reading

With 58.9% CAGR, Smart Flooring Market Size Worth USD 5,873.3 Million by 2030

According to Fortune Business Insights, the global Smart Flooring Market size is projected to reach USD 5,873.3 Million by 2030, at a CAGR of 58.9% during the forecast period, 2023-2030 Pune, India, April 17, 2023 (GLOBE NEWSWIRE) — The global smart flooring market size was valued at USD 151.7 million in 2022 and is expected to be worth USD 230.1 million in 2023. The market is projected to touch USD 5,873.3 million by 2030, registering a CAGR of 58.9% during the forecast period of 2023-2030. Rising Use of Smart Floors across Retail Sector and Kinetic Dance Floors to Augment Market Growth. Fortune Business Insights™ displays this information in a report titled, “Global Smart Flooring Market Forecast, 2023-2030.” Key Industry Development: April 2021: Pavegen installed a kinetic tech floor at the U.K.’s first train...

Continue reading

Enterprise Resource Planning Software Market Size to Hit USD 71.34 Billion by 2030, Exhibiting a CAGR of 6.2%

As per the report by Fortune Business Insights, the global enterprise resource planning software market size is projected to reach USD 71.34 billion in 2030, at a CAGR of 6.2% during the forecast period, 2023-2030 Pune, India, April 17, 2023 (GLOBE NEWSWIRE) — The global enterprise resource planning software market size was valued at USD 44.47 billion in 2022. The market is projected to grow from USD 46.86 billion in 2023 to USD 71.34 billion by 2030, exhibiting a CAGR of 6.2% during the forecast period. Increasing Need for Automation to Drive Market Forward. Fortune Business Insights presents this information in their report titled “Enterprise Resource Planning Software Market Forecast, 2023–2030.”Request a Free Sample PDF: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/enterprise-resource-planning-erp-software-market-102498Key...

Continue reading

Gritstone bio Presents 6-month Neutralizing Antibody (nAb) Data at ECCMID 2023 from Two Phase 1 Studies Evaluating Self-amplifying mRNA (samRNA) Against SARS-CoV-2 (CORAL)

— CORAL-CEPI: Primary series samRNA vaccination elicits strong neutralizing antibody (nAb) responses that persist for at least 6 months, including variant cross-reactive nAb, in previously unvaccinated (“vaccine-naïve”) South African subjects — — Updated CORAL-BOOST: Boost samRNA vaccine elicits robust nAbs that persist for at least 6 months regardless of primary series (adenovirus or mRNA) — — Data further support the favorable tolerability and distinctive immunogenicity profile of self-amplifying mRNA (samRNA) — EMERYVILLE, Calif., April 17, 2023 (GLOBE NEWSWIRE) — Gritstone bio, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company working to develop the world’s most potent vaccines, today presented 6-month follow up data from its ongoing Phase 1 CORAL-CEPI and CORAL-BOOST studies, which...

Continue reading

Kineta Unveils New VISTA Biomarker Data and KVA12123 Phase 1/2 Clinical Trial Update at AACR Annual Meeting 2023

SEATTLE, April 17, 2023 (GLOBE NEWSWIRE) — Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune resistance, announced today the presentation of new VISTA biomarker data and an update on the KVA12123 Phase 1/2 clinical trial at the American Association for Cancer Research (AACR) Annual Meeting 2023. Thierry Guillaudeux, Ph.D., Chief Scientific Officer at Kineta, presented the company’s poster unveiling the new data in the AACR poster session entitled “Biomarkers of Therapeutic Benefit 1”. “These biomarker data provide additional compelling rationale supporting VISTA as a promising new immuno-oncology target for patients with a range of different cancers” said Dr. Guillaudeux. “A better understanding of VISTA expression in the...

Continue reading

FTAI Infrastructure Inc. Announces Timing of First Quarter Earnings and Conference Call

NEW YORK, April 17, 2023 (GLOBE NEWSWIRE) — FTAI Infrastructure Inc. (NASDAQ:FIP; the “Company” or “FTAI Infrastructure”) plans to announce its financial results for the first quarter 2023 after the closing of Nasdaq on Tuesday, May 2, 2023. A copy of the press release and an earnings supplement will be posted to the Investor Relations section of the Company’s website, https://www.fipinc.com/. In addition, management will host a conference call on Wednesday, May 3, 2023 at 8:00 A.M. Eastern Time. The conference call may be accessed by registering via the following link:https://register.vevent.com/register/BI76e04d920aa34a3db8931a5a75020dc8. Once registered, participants will receive a dial-in and unique pin to access the call. A simultaneous webcast of the conference call will be available to the public on a listen-only...

Continue reading

PureGold to be Acquired by West Red Lake Gold Mines Ltd.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, April 17, 2023 (GLOBE NEWSWIRE) — Pure Gold Mining Inc. (NEX:PGM.H) (the “Company”) announces that it has entered into a binding letter agreement with West Red Lake Gold Mines Ltd. (“West Red Lake” or “WRLG”) (TSXV: WRLG, OTC: WRLGF) and Sprott Resource Lending Corp. (“Sprott”), whereby WRLG will, subject to certain conditions precedent, acquire all of the issued and outstanding shares of the Company (the “Acquisition”), subject to approval of the British Columbia Supreme Court (the “Court”) in the Company’s ongoing proceedings pursuant to the Companies Creditors Arrangement Act (the “CCAA Proceedings”). WRLG has agreed to pay C$6.5 million in cash, issue 28.46 million common shares and grant a 1.0% secured...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.